bromocriptina dorom
teva italia s.r.l. - bromocriptina - bromocriptina
parlodel
viatris healthcare limited - bromocriptina - bromocriptina
bromocriptina
sandoz s.p.a. - bromocriptina - bromocriptina
serocryptin
merck serono s.p.a. - bromocriptina - bromocriptina
metilergometrina maleato pfizer
pfizer italia s.r.l. - metilergometrina - metilergometrina
parlodel compresse
sandoz pharmaceuticals ag - bromocriptinum - compresse - bromocriptinum 2.5 mg ut bromocriptini mesilas, silica colloidalis anhydrica, dinatrii edetas corresp. natrium 0.0618 mg, magnesii stearas, acidum maleicum, maydis amylum, amylum pregelificatum, lactosum monohydricum 116.38 mg, pro compresso. - iperprolattinemia, prolaktinom, acromegalia, medico indicizzati laktationshemmung - synthetika
methergin
novartis farma s.p.a. - metilergometrina - metilergometrina
octreotide gp-pharm
gp-pharm s.a. - octreotide - octreotide
sandostatina
novartis farma s.p.a. - octreotide - octreotide
mycapssa
amryt pharmaceuticals dac - octreotide acetate - acromegalia - ormoni ipofisari e ipotalamici e analoghi - mycapssa is indicated for maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.